Albany, NY -- (SBWIRE) -- 07/25/2017 -- Global Legionella Testing Market: Snapshot
The global market for legionella testing is gaining traction from a number of factors, including rising incidence of pneumonia and legionella-related illnesses, technological advancements in the field of bacterial testing, and increasing demand for advanced diagnostic techniques. On the other hand, the global legionella testing market is hindered by a few factors, such as insufficient disposable income in a number of emerging economies and complex regulatory framework that obstructs the product approvals. As per the estimations of the Centers for Disease Control and Prevention (CDC), nearly 4,548 people were diagnosed with legionnaires' diseases in 2013, and the number continues to escalate with increasing contamination of the environment and the lack of hygiene. In the near future, the global legionella testing market is projected to expand at a healthy CAGR during the forecast period of 2016 to 2024.
This report on the global legionella testing market has been developed by a group of professional market research analysts, aspiring to serve as a credible business tool for the targeted audiences such as the manufacturers of equipment used for the diagnostic of legionella, government agencies, and traders and distributors. Based on application, the global legionella testing market can be segmented into water testing, including DFA strain, PCR, and microbial culture, and IVD testing, which includes urine antigen test, blood culture, DFA stain, and PCR. This report provides in-depth assessment of all factors that may influence the demand in the legionella testing market, highlights the potential of the most important geographical regions, and profiles a number of leading companies in order to represent the competitive landscape.
Global Legionella Testing Market: Overview
Legionella testing has become an important part of the healthcare scenario in many developed countries in recent years. Even though legionella is noncontagious and doesn't always cause diseases, testing for its presence is a necessary step in minimizing the spread of diseases in a country's population. Even though legionella needs a specific set of circumstances to thrive, it can survive with minimal oxygen and is immune to chlorine. As a result, legionella testing has become a part of the healthcare sector protocol in several countries, leading to a steady rise in the demand for legionella testing procedures and equipment.
The report studies the global legionella testing market comprehensively, taking into account the market's geographical breakdown, competitive landscape, and pricing pressures. This helps readers get a clear idea about the leading regional markets for legionella testing, the key players operating in the global legionella testing market, and the micro- and macroeconomic factors that affect the pricing structure of the legionella testing industry.
Antimicrobial therapy is the most commonly practiced remedy against legionella diseases and takes up a significant share in the global legionella testing market. Some of the leading antibiotics used in the treatment of legionella diseases are quinolones, tetracyclines, macrolides, ketolides, and rifampin. Fluoroquinolones are considered effective medication against legionella diseases.
Global Legionella Testing Market: Trends and Opportunities
The steady advancement in the field of immunodiagnostics has been the crucial driver for the global legionella testing market. The intensive research into medical technology, optics technology, and microbiology in recent years has enabled smooth development of improved immunodiagnostic technologies. The rising use of automation technologies in diagnostics is another key factor expected to aid the expansion of the global legionella testing market in the coming years.
Due to the widespread prevention measures being employed in developed regions, the legionella testing market is strong in developed countries. On the other hand, the increasing awareness about the risks of legionella has led to steady growth of the legionella testing market in emerging regions such as Asia Pacific and Latin America. Legionella, if untreated, can cause wounds and complications such as kidney failure, lung failure, and septic shock. The rising awareness regarding the same is a crucial driver for the global legionella testing market.
Another key driver for the global legionella testing market is the entry of new players in the market. The healthcare sector has become a prime investment hub in the last few years, which has drastically restructured the pricing structure of the industry. This is likely to remain a key driver for the legionella testing market in the coming years, as the untapped healthcare sector in emerging regions such as Southeast Asia and Latin America has significant potential for new investment.
Global Legionella Testing Market: Geographical and Competitive Landscape
The leading contributors to the global legionella testing market are North America and Europe. The high number of legionella patients in North America and the presence of several of the industry's key players has led to steady dominance of the region in the global legionella testing market, while the supportive stance of European countries such as Germany and the UK towards advanced healthcare research has also allowed them to gain a vital place in the global legionella testing market's hierarchy. The extensive promotion of legionella medication in Europe in recent years is thus likely to remain a key driver for the Europe legionella testing market in the coming years.
The report also sheds light on the competitive workings of the global legionella testing market by profiling leading players such as Abbott Laboratories, Life Technology, Beckman Coulter, Novartis Diagnostics, Roche Diagnostics, and Bio-Rad Laboratories.
Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Legionella Testing Market during 2016- 2024